Asthma & COPD 2017 London, England, UK 29-30 March 2017

Description:
Aimed at senior scientists and respiratory and inhalation specialists, Asthma & COPD 2017 will reflect on the ongoing issues and latest developments of these two diseases.

With a carefully selected panel of industry experts, the 2017 event will address the latest challenges and changes in the fields of asthma and COPD. The agenda will explore novel approaches to treatment, including cutting edge developments in triple combination therapies and phenotyping. As well as identify challenges to device development and delivery, deepen our understanding of the problems relating to these diseases, and discuss the hot topic of electronic health monitoring.

Featured Speakers:
• Quan Yang, Pharmaceutical Assessor, MHRA
• Stephen Beckman, Head of Global Respiratory and Allergy, Mylan
• Outi Vaarala, Vice President, Head of Translational Biology, AstraZeneca
• Ewan Walters, Medical Director, Teva UK
• David Leather, Global Medical Affairs Leader, GlaxoSmithKline
• Stefan Leiner, Chemical-Pharmaceutical Expert, Boehringer Ingelheim
• Neelima Khairatkar Joshi, Senior Vice President & Head of Drug Discovery, Glenmark Pharmaceuticals
• Christopher Stevenson, Venture Leader COPD Interception, Janssen
• Marianna Alacqua, Senior Global Medical Affairs Leader of Respiratory Biologics, AstraZeneca
• Frank Thielmann, Operational Lead Inhalation New Solids, Novartis

Prices:
Standard: GBP 1499,
Standard by 30/11/2016: GBP 1099,
Standard by 16/12/2016: GBP 1299,
Standard by 31/01/2016: GBP 1399,
WORKSHOP A: GBP 599,
WORKSHOP B: GBP 599